Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies von Graham, Laura S, Montgomery, Bruce, Cheng, Heather H, Yu, Evan Y, Nelson, Peter S, Pritchard, Colin, Erickson, Stephanie, Alva, Ajjai, Schweizer, Michael T

Volltext

A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer von Schweizer, Michael T, Haugk, Kathleen, McKiernan, Jožefa S, Gulati, Roman, Cheng, Heather H, Maes, Jessica L, Dumpit, Ruth F, Nelson, Peter S, Montgomery, Bruce, McCune, Jeannine S, Plymate, Stephen R, Yu, Evan Y

Volltext

Immunotherapy for prostate cancer: recent developments and future challenges von Schweizer, Michael T., Drake, Charles G.

Volltext

MSH2 Loss in Primary Prostate Cancer von Guedes, Liana B, Antonarakis, Emmanuel S, Schweizer, Michael T, Mirkheshti, Nooshin, Almutairi, Fawaz, Park, Jong Chul, Glavaris, Stephanie, Hicks, Jessica, Eisenberger, Mario A, De Marzo, Angelo M, Epstein, Jonathan I, Isaacs, William B, Eshleman, James R, Pritchard, Colin C, Lotan, Tamara L

Volltext

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer von Carlson, Alexander S, Acevedo, Rigo I, Lim, Daniel M, Gulati, Roman, Gawne, Agnes, Sokolova, Alexandra O, Cheng, Heather H, Nelson, Peter S, Montgomery, R Bruce, Yu, Evan Y, Schweizer, Michael T

Volltext

Microsatellite instability in prostate cancer by PCR or next-generation sequencing von Hempelmann, Jennifer A, Lockwood, Christina M, Konnick, Eric Q, Schweizer, Michael T, Antonarakis, Emmanuel S, Lotan, Tamara L, Montgomery, Bruce, Nelson, Peter S, Klemfuss, Nola, Salipante, Stephen J, Pritchard, Colin C

Volltext

Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate ca... von Reed-Perino, Darien E, Lai, Michael, Yu, Evan Y, Schweizer, Michael T

Volltext

Chemotherapy and its evolving role in the management of advanced prostate cancer von Schweizer, Michael T, Antonarakis, Emmanuel S

Volltext

Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born von Schweizer, Michael T., Antonarakis, Emmanuel S.

Volltext

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer von Sayar, Erolcan, Patel, Radhika A, Coleman, Ilsa M, Roudier, Martine P, Zhang, Ailin, Mustafi, Pallabi, Low, Jin-Yih, Hanratty, Brian, Ang, Lisa S, Bhatia, Vipul, Adil, Mohamed, Bakbak, Hasim, Quigley, David A, Schweizer, Michael T, Hawley, Jessica E, Kollath, Lori, True, Lawrence D, Feng, Felix Y, Bander, Neil H, Corey, Eva, Lee, John K, Morrissey, Colm, Gulati, Roman, Nelson, Peter S, Haffner, Michael C

Volltext

Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer von Schweizer, Michael T, Haugk, Kathleen, McKiernan, Jožefa S, Gulati, Roman, Cheng, Heather H, Maes, Jessica L, Dumpit, Ruth F, Nelson, Peter S, Montgomery, Bruce, McCune, Jeannine S, Plymate, Stephen R, Yu, Evan Y

Volltext

Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss von Markowski, Mark C., Wang, Hao, De Marzo, Angelo M., Schweizer, Michael T., Antonarakis, Emmanuel S., Denmeade, Samuel R.

Volltext

Hormone levels following surgical and medical castration: defining optimal androgen suppression von Schweizer, Michael, Hancock, Michael, Getzenberg, Robert, Yu, Evan

Volltext

Mismatch repair deficiency and clinical implications in prostate cancer von Graham, Laura S., Schweizer, Michael T.

Volltext

First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-res... von Autio, Karen A, Higano, Celestia S, Nordquist, Luke, Appleman, Leonard J, Zhang, Tian, Zhu, Xin-Hua, Babiker, Hani, Vogelzang, Nicholas J, Prasad, Sandip M, Schweizer, Michael T, Madan, Ravi A, Billotte, Stephane, Cavazos, Nora, Bogg, Orlaith, Li, Ray, Chan, Kam, Cho, Helen, Kaneda, Megan, Wang, I-Ming, Zheng, Jenny, Tang, Szu-Yu, Hollingsworth, Robert, Kern, Kenneth A, Petrylak, Daniel P

Volltext

Targeting intratumoral androgens: statins and beyond von Schweizer, Michael T., Yu, Evan Y.

Volltext

Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer von De Sarkar, Navonil, Dasgupta, Sayan, Chatterjee, Payel, Coleman, Ilsa, Ha, Gavin, Ang, Lisa S, Kohlbrenner, Emily A, Frank, Sander B, Nunez, Talina A, Salipante, Stephen J, Corey, Eva, Morrissey, Colm, Van Allen, Eliezer, Schweizer, Michael T, Haffner, Michael C, Patel, Radhika, Hanratty, Brian, Lucas, Jared M, Dumpit, Ruth F, Pritchard, Colin C, Montgomery, Robert B, Nelson, Peter S

Volltext

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates von Ajkunic, Azra, Sayar, Erolcan, Roudier, Martine P., Patel, Radhika A., Coleman, Ilsa M., De Sarkar, Navonil, Hanratty, Brian, Adil, Mohamed, Zhao, Jimmy, Zaidi, Samir, True, Lawrence D., Sperger, Jamie M., Cheng, Heather H., Yu, Evan Y., Montgomery, Robert B., Hawley, Jessica E., Ha, Gavin, Persse, Thomas, Galipeau, Patricia, Lee, John K., Harmon, Stephanie A., Corey, Eva, Lang, Joshua M., Sawyers, Charles L., Morrissey, Colm, Schweizer, Michael T., Gulati, Roman, Nelson, Peter S., Haffner, Michael C.

Volltext

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer von Labrecque, Mark P, Coleman, Ilsa M, Brown, Lisha G, True, Lawrence D, Kollath, Lori, Lakely, Bryce, Nguyen, Holly M, Yang, Yu C, da Costa, Rui M Gil, Kaipainen, Arja, Coleman, Roger, Higano, Celestia S, Yu, Evan Y, Cheng, Heather H, Mostaghel, Elahe A, Montgomery, Bruce, Schweizer, Michael T, Hsieh, Andrew C, Lin, Daniel W, Corey, Eva, Nelson, Peter S, Morrissey, Colm

Volltext

Hypermutation, Mismatch Repair Deficiency, and Defining Predictors of Response to Checkpoint Blockade von Graham, Laura S, Pritchard, Colin C, Schweizer, Michael T

Volltext